RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Inventories

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndInventories (Million USD)YoY (%)
Dec 31, 20243,007-25.22%
Dec 31, 20234,021+4.90%
Dec 31, 20223,833+0.39%
Dec 31, 20213,818-13.29%
Dec 31, 20204,403-0.43%
Dec 31, 20194,422-6.53%
Dec 31, 20184,731-3.92%
Dec 31, 20174,924-0.61%
Dec 31, 20164,954+24.91%
Dec 31, 20153,966-9.27%
Dec 31, 20144,371-13.50%
Dec 31, 20135,053-8.16%
Dec 31, 20125,502+9.78%
Dec 31, 20115,012+29.64%
Dec 31, 20103,866

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)